or
forgot password
  • cancer clinical trials in reading, PA

  • AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Esophageal Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer, Fatigue, Sleep Disorders
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Saint Joseph Medical Center
    Reading, Pennsylvania 19605
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Multiple Myeloma, Plasma Cell Neoplasm
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer, Fatigue, Neurotoxicity
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Ovarian Cancer, Sarcoma
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of 05/14/10)
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Cancer
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Saint Joseph Medical Center
    Reading, Pennsylvania 19605
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Lung Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Breast Cancer
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Reading Hospital and Medical Center

    Trial Locations
    Reading Hospital and Medical Center
    Saint Joseph Medical Center
    Breast Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Cervical Cancer, Endometrial Cancer, Gastrointestinal Complications, Perioperative/Postoperative Complications, Radiation Toxicity, Urinary Complications, Urinary Tract Toxicity
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Lung Cancer
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Metastatic Cancer
    Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Sarcoma
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Head and Neck Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Prostate Cancer
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Breast Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Reading Hospital and Medical Center
    Reading, Pennsylvania 19612-6052
    Brain and Central Nervous System Tumors